Nouscom
PrivateLast Round
Series C
Mar 21, 2024
Total Funding Raised
$226.6M
Company Overview
Nouscom is a biotechnology company that develops engineered viral vector vaccines for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nouscom Comparables
Compare Nouscom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transgene SA | 80% | |
| Gritstone bio | 78% | |
| Nykode Therapeutics | 78% |
Nouscom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 21, 2024 | ||||
| Series C | Nov 14, 2023 | ||||
| Series B | Nov 6, 2017 | ||||
| Series A | May 17, 2016 |
Key People
Founding team and executive leadership
Nouscom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series C, Series B, Series A |
| XGEN Venture | Series C |
| Andera Partners | Series C |
| M Ventures | Series C |
| Indaco Venture Partners SGR | Series C |
| 5AM Ventures | Series B, Series C |
| Versant Ventures | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 21, 2024
$82M round led by Andera Partners and M Ventures.
- Nov 14, 2023
$82M round raised
Nouscom Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nouscom's valuation, stock price, and market status.
Is Nouscom a public or private company?
Nouscom is a private company.
What is the current stock price of Nouscom?
Nouscom is a private company with no public stock price. No recent secondary market data is available.
How much is Nouscom worth (valuation)?
Valuation information for Nouscom is not publicly available.
Can I buy Nouscom stock?
Nouscom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nouscom's last funding round?
Nouscom's most recent funding round was Series C on March 21, 2024.
Who are the main investors in Nouscom?
Key investors in Nouscom include Andera Partners, M Ventures, Bpifrance, Versant Ventures, Abingworth.
Will Nouscom IPO soon?
No public IPO plans have been announced for Nouscom.
How can I track Nouscom secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nouscom's secondary market activity and sign up for updates.